Ameri Hospice 50 Business Parkway Suite F-2, Richardson, TX, 75081 | |
(877) 786-0099 |
News Archive
The first of its kind, the review showed 461 cases of links between racism and child and youth health outcomes.
ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
State officials from different political perspectives expressed interest in establishing health insurance exchanges, and an administration official promised "a wide berth" in how states choose to construct parts of the reform law.
› Verified 8 days ago
Name | Ameri Hospice |
---|---|
Location | 50 Business Parkway Suite F-2, Richardson, Texas |
Hospice ID | 741651 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | Community Health Accreditation Partner (CHAP) |
SSA county code | 390 |
News Archive
The first of its kind, the review showed 461 cases of links between racism and child and youth health outcomes.
ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
State officials from different political perspectives expressed interest in establishing health insurance exchanges, and an administration official promised "a wide berth" in how states choose to construct parts of the reform law.
› Verified 8 days ago
NPI Number | 1679853881 |
Organization Name | Amerihealth Group Inc |
Address | 50 Business Pkwy Richardson, Texas, 75081 |
Phone Number | (972)900-0207 |
News Archive
The first of its kind, the review showed 461 cases of links between racism and child and youth health outcomes.
ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
State officials from different political perspectives expressed interest in establishing health insurance exchanges, and an administration official promised "a wide berth" in how states choose to construct parts of the reform law.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
The first of its kind, the review showed 461 cases of links between racism and child and youth health outcomes.
ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
State officials from different political perspectives expressed interest in establishing health insurance exchanges, and an administration official promised "a wide berth" in how states choose to construct parts of the reform law.
› Verified 8 days ago
Home Health Aides | 1.5 |
Counselors | 0.5 |
Medical Social Workers | 0.5 |
Registered Nurses | 0.5 |
Other Personnel | 1 |
Total Employees | 4 |
---|
News Archive
The first of its kind, the review showed 461 cases of links between racism and child and youth health outcomes.
ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
State officials from different political perspectives expressed interest in establishing health insurance exchanges, and an administration official promised "a wide berth" in how states choose to construct parts of the reform law.
› Verified 8 days ago
Others | 0.5 |
Total Volunteers | 0.5 |
---|
News Archive
The first of its kind, the review showed 461 cases of links between racism and child and youth health outcomes.
ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.
A recent video from the Center for Strategic & International Studies (CSIS) on global health and national security discusses the importance of military and non-military health partnerships with middle- and low-income countries, the American Public Health Association's "IH-Blog" reports.
State officials from different political perspectives expressed interest in establishing health insurance exchanges, and an administration official promised "a wide berth" in how states choose to construct parts of the reform law.
› Verified 8 days ago
Angel Care Hospice Location: 1701 N Greenville Ave St #1109, Richardson, Texas, 75081 Phone: (877) 786-0099 |
Total Hospice And Palliative Care Location: 331 Melrose Drive, Suite 230, Richardson, Texas, 75080 Phone: (877) 786-0099 |
Bella Hospice And Healthcare Llc Location: 2093 Collins Blvd, Suite A, Richardson, Texas, 75080 Phone: (877) 786-0099 |
Ameriprime Hospice Llc Location: 50 Business Parkway Suite B, Richardson, Texas, 75081 Phone: (877) 786-0099 |